NDC 71225-114

Icatibant

Icatibant

Icatibant is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Slayback Pharma Llc. The primary component is Icatibant Acetate.

Product ID71225-114_5ccd1185-cbec-4c7f-a654-95f8ff1a7e01
NDC71225-114
Product TypeHuman Prescription Drug
Proprietary NameIcatibant
Generic NameIcatibant
Dosage FormInjection
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2020-09-03
Marketing CategoryANDA / ANDA
Application NumberANDA211501
Labeler NameSlayback Pharma LLC
Substance NameICATIBANT ACETATE
Active Ingredient Strength30 mg/3mL
Pharm ClassesBradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71225-114-01

1 SYRINGE, GLASS in 1 CARTON (71225-114-01) > 3 mL in 1 SYRINGE, GLASS
Marketing Start Date2021-01-28
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Icatibant" or generic name "Icatibant"

NDCBrand NameGeneric Name
0093-3066IcatibantIcatibant
24201-207Icatibanticatibant
54092-135IcatibantIcatibant
60505-6214ICATIBANTicatibant acetate
63323-574IcatibantIcatibant
68462-828Icatibanticatibant acetate
69097-664ICATIBANTICATIBANT
71225-114IcatibantIcatibant
70709-013SAJAZIRICATIBANT

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.